Log In
Print this Print this

Cycloset, bromocriptine mesylate

Also known as: formerly Ergoset

  Manage Alerts
Collapse Summary General Information
Company VeroScience LLC
DescriptionBromocriptine timed-release tablets
Molecular Target Dopamine D2 receptor
Mechanism of ActionDopamine D2 receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationDiabetes
Indication DetailsTreat diabetes; Treat diabetes and obesity; Treat insulin secretory dysfunction; Treat non-insulin-dependent Type II diabetes; Treat obese Type II diabetics; Treat obesity or diabetes; Treat Type II diabetes; Treat Type II diabetes requiring insulin
Regulatory Designation
Partner Valeant Pharmaceuticals International Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today